GINGEMBRE
Natural health product licensed in Canada
- Licence holder
- Lyo-San Inc.
- NPN or DIN-HM
- 80002063
- Status
- Active licence
- Licence date
- 29 August 2006
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Utilisé traditionellement comme spasmolytique. Aide à soulanger les malaise digestifs, y compris la flatulence, l'indegestition et la constipation spasmodique. Aide à prévenir la nausée et les vomissements associés au mal des transports, à la nausée post-opéartiore et au mal de mer. Aide à soulanger les douleurs menstruelles
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un practicien de soins de santé avant l'utilisation si vous avez des troubles de la coagulation sanguine et/ou si vous prenezdes anticoagulants. Consulter un practicien de soins de santé dans les suivants: calcuis biliaires, Malaises Abdonminaux, de brûures d'estomac et/ou si un effet d'irritation dans la bouche et la gorge persiste. Garder hors de la portée des enfants.
- Contre-indications
Ne pas utiliser en cas de grossesseou allaitement.
Source
Official Health Canada record, licence 80002063
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.